Leonhardt Ventures
  • Home
  • About
    • About us
    • 2021 Top Achievements
    • Leonhardt Ventures Portfolio Clinical Trials Listing
    • Founder Bio
    • Development Pipeline
    • Regenerative Medtech
    • Media
      • Company Logos
    • LV Team
      • Board of Directors
      • Team
      • Portfolio Startups Boards
      • Scientific Advisory Board
  • Our Startups
  • News
  • Investors
    • Invest in us
    • Agreements & Forms
      • Agreement Forms
      • Master Patent IP License and Development Agreement
      • Accelerator Membership Agreement
      • Term Sheet
      • 409a Valuation Accelerator
    • Leonhardts Launchpads
      • Leonhardt’s Launchpads Valuations
      • Accelerator Business Model
      • 2019 Elevator Pitches
      • Cap Tables and Valuations
    • Important
      • 2022 Budget
      • Legal Terms Summary
      • Board Governance
      • 2020 Goals
      • Current Clinical Trials
      • Executive Summary
    • Clinical Studies
      • Clinical Study Enrollment 10/1/19
    • Investor FAQ
    • Annual Reports
      • 2016-2020
        • 2021 Annual Report
        • 2020 Annual Report
        • 2019 Annual Report
        • 2018 Annual Report
        • 2017 Annual Report
        • 2016 Annual Report
      • 2012-2015
        • 2015/16 Annual report
        • 1Q 2015 Newsletter
        • 2013/14 Annual Newsletter
        • 2012 Fall Newsletter
  • Contact
Select Page

Leonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day

by hleonhardt | Jan 19, 2022 | Uncategorized

Showcased technologies include a novel circulatory assist pump for heart failure and bioelectric and biologic treatments for erectile dysfunction, skin and hair regeneration, and rapid straightening and stabilization of teeth during orthodontic treatment.  NEWS...

Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer

by hleonhardt | Jan 19, 2022 | Uncategorized

Published: Dec 22, 2021 Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) — Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing, today announced that the U.S. Patent and...

Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing

by hleonhardt | Jan 19, 2022 | Uncategorized

Published: Dec 29, 2021   Mission Viejo, California, United States, Dec. 29, 2021 (GLOBE NEWSWIRE) — Leonhardt Ventures LLC, an innovation and venture creation company focused on the convergence of bioelectrics and biologics for organ regeneration,...

Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer

by hleonhardt | Jan 19, 2022 | Uncategorized

Published: Dec 22, 2021 Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) — Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing, today announced that the U.S. Patent and...

Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation

by hleonhardt | Dec 31, 2021 | Uncategorized

Mission Viejo, CA (PRDistribution) – Dec. 30th, 2021 – Leonhardt Ventures LLC announced today filing of a patent application covering bioelectric controlled down regulation of FABp4 and up regulation of klotho for the potential purpose of reversing type 1...

University Lab Partners @ UCI Cove Leonhardt Custom Bioelectric Inflammation Treatment Patent Issued by USPTO

by hleonhardt | Nov 5, 2021 | Uncategorized

« Older Entries
Next Entries »

Recent Posts

  • May 9, 2022 Update Leonhardt Ventures LLC and Leonhardt’s Launchpads
  • Mind of an Innovator Slide Deck for Innovation Week 2022
  • The Mind of an Innovator Creator
  • Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
  • Leonhardt Ventures LLC Issued Pioneering Patent for Bioelectric Inflammation Treatment Device and Method
  • Facebook
  • Twitter
© Copyright Leonhardt Ventures | Website by FizzPOP Media